Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prothrombin as cofactor for antiphospholipids

M Galli1, T Barbui

  • 1Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy. ematologia@cyberg.it

Lupus
|November 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Light scattering properties of self-organized nanostructured substrates for thin-film solar cells.

Nanotechnology·2018
Same author

Chagas disease knocks on our door: a cross-sectional study among Latin American immigrants in Milan, Italy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Does focal mechanical stimulation of the lower limb muscles improve postural control and sit to stand movement in elderly?

Aging clinical and experimental research·2018
Same author

A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis.

Journal of pain research·2017
Same author

Groin Pain Syndrome Italian Consensus Conference on terminology, clinical evaluation and imaging assessment in groin pain in athlete.

BMJ open sport & exercise medicine·2017
Same author

Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
Same journal

Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators.

Lupus·2026
See all related articles

Anti-prothrombin antibodies are common in patients but their clinical relevance remains unclear. Specific coagulation tests can differentiate them from anti-beta2-glycoprotein I antibodies, potentially aiding risk assessment.

Area of Science:

  • Immunology
  • Hematology
  • Clinical Chemistry

Background:

  • Prothrombin is a frequent target for antiphospholipid antibodies (aPLAs), found in 50-90% of patients.
  • Anti-prothrombin antibodies are implicated in lupus anticoagulant activity, often alongside anti-beta2-glycoprotein I antibodies.
  • The specific epitopes targeted by anti-prothrombin antibodies are not yet identified.

Purpose of the Study:

  • To investigate the role and clinical significance of anti-prothrombin antibodies in antiphospholipid syndrome.
  • To differentiate anti-prothrombin antibodies from anti-beta2-glycoprotein I antibodies using coagulation assays.
  • To assess the association of anti-prothrombin antibodies with thrombotic risk.

Main Methods:

  • Detection of anti-prothrombin antibodies in patient sera.

Related Experiment Videos

  • Utilizing Kaolin Clotting Time (KCT) and dilute Russell's Viper Venom Time (dRVVT) assays to generate distinct coagulation profiles.
  • Comparison of KCT and dRVVT profiles to discriminate between antibody types.
  • Review of existing studies measuring anti-prothrombin antibodies via ELISA and their association with thrombosis.

    • Main Results:

    • Anti-prothrombin antibodies are detected in a high percentage of patients and contribute to lupus anticoagulant activity.
    • Distinct coagulation profiles (KCT vs. dRVVT) can differentiate anti-prothrombin from anti-beta2-glycoprotein I antibodies.
    • The KCT profile, associated with anti-prothrombin antibodies, may indicate a lower risk of thrombosis.
    • ELISA-based studies have generally failed to establish a significant link between anti-prothrombin antibodies and thrombosis.

    Conclusions:

    • While anti-prothrombin antibodies are prevalent and detectable via specific coagulation profiles, their direct clinical relevance and association with thrombosis are not definitively established.
    • The distinction between anti-prothrombin and anti-beta2-glycoprotein I antibodies, though artificial, may offer clinical utility in risk stratification.
    • Further research is needed to clarify the precise role and impact of anti-prothrombin antibodies in clinical practice.